Updated Jul 16, 2026
Johnson Philip L has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Philip L. Johnson is an executive in the pharmaceutical industry, currently serving as the Executive Vice President and Chief Financial Officer of Jazz Pharmaceuticals plc. He has extensive experience in financial management and strategic planning within the healthcare sector.
| Role | EVP & Chief Financial Officer |
|---|---|
| Notability | 75/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-02 | JAZZ | Jazz Pharmaceuticals plc | F — Tax withholding / forfeiture | 3.3K | $237.72 | $795K |
| 2026-03-09 | JAZZ | Jazz Pharmaceuticals plc | F — Tax withholding / forfeiture | 2.6K | $188.69 | $493K |
| 2026-03-02 | JAZZ | Jazz Pharmaceuticals plc | A — Grant or award | 11.9K | $0.00 |
Philip L. Johnson is an executive in the pharmaceutical industry, currently serving as the Executive Vice President and Chief Financial Officer of Jazz Pharmaceuticals plc. He has extensive experience in financial management and strategic planning within the healthcare sector.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Johnson Philip L profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.